Categories AlphaGraphs, Earnings, Health Care
Pfizer (PFE) Q2 2024 Earnings: Key financials and quarterly highlights
Pfizer Inc. (NYSE: PFE) reported its second quarter 2024 earnings results today.
Revenues increased 2% year-over-year to $13.3 billion. Revenues grew 3% operationally.
Reported net income fell 98% to $41 million, or $0.01 per share, compared to last year. Adjusted EPS dropped 11% to $0.60.
For the full year of 2024, Pfizer expects revenues of $59.5-62.5 billion. Adjusted EPS is expected to be $2.45-2.65.
Prior performance
Listen to the conference calls as they happen. Don't miss a beat! With AlphaStreet Intelligence, you can listen to live calls and interviews as they happen, so you never have to worry about missing out on important information.
Most Popular
Important takeaways from Conagra Brands’ Q4 2025 report
Conagra Brands, Inc. (NYSE: CAG), a leading provider of consumer packaged goods, reported weaker-than-expected sales and adjusted earnings for its fourth quarter, reflecting ongoing economic uncertainty and muted consumer spending.
Delta Air Lines (DAL) gains on strong Q2 2025 performance
Shares of Delta Air Lines (NYSE: DAL) rose 12% on Thursday after the company delivered strong results for the second quarter of 2025 and restored its guidance for the full
CAG Earnings: Conagra Brands Q4 adj. profit drops, misses estimates
Conagra Brands, Inc. (NYSE: CAG), a leading provider of consumer packaged goods, reported lower sales and adjusted earnings for the fourth quarter of 2025. Results missed analysts' estimates. Net sales
